Cannabis-Focused Biotech Surges After Seizure Drug Outsells Estimates

Sales of GW Pharmaceuticals' seizure medicine, Epidiolex, easily topped Wall Street's first-quarter expectations Monday, leading GWPH stock to pop. Losses were also better than expected. Read More...